Length of hospitalisation (days) · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Duration of antimicrobial treatment (days) · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
All‐cause mortality · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in mortality compared with inpatients ‐ adults (moderate certainty).
1 finding from 1 review
Fever clearance time · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Adverse drug reactions · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in adverse drugs reactions compared with inpatients ‐ adults (low certainty).
1 finding from 1 review
Length of hospitalisation (days) · Adult patients with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Treatment failure · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in treatment failure compared with inpatients ‐ children (moderate certainty).
1 finding from 1 review
All‐cause mortality · Children with cancer who develop a low‐risk febrile neutropaenic event
Outpatients showed no clear difference in mortality compared with inpatients ‐ children (moderate certainty).
1 finding from 1 review
Fever clearance time · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
All‐cause mortality · paediatric patients following heart surgery
Prophylactic levosimendan showed no clear difference in mortality compared with standard treatment (low certainty).
1 finding from 1 review
Low cardiac output syndrome (LCOS) · paediatric patients following heart surgery
Prophylactic levosimendan showed no clear difference in low cardiac output syndrome (LCOS) compared with standard treatment (low certainty).
1 finding from 1 review
Duration of ICU stay · paediatric patients following heart surgery
1 finding from 1 review
Length of hospital stay · paediatric patients following heart surgery
1 finding from 1 review
Duration of mechanical ventilation · paediatric patients following heart surgery
1 finding from 1 review
Mechanical circulatory support or cardiac transplantation · paediatric patients following heart surgery
Prophylactic levosimendan showed no clear difference in mechanical circulatory support or cardiac transplantation compared with standard treatment (low certainty).
1 finding from 1 review
Intervention not reported
Transitional readiness (TRAQ) · adolescents between 12 and 19 years with any chronic condition requiring ongoing clinical care, who are leaving or transitioning from…
1 finding from 1 review
Intervention not reported
Use of health services · adolescents between 12 and 19 years with any chronic condition requiring ongoing clinical care, who are leaving or transitioning from…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Patient initiated health care communication (no tool) · adolescents between 12 and 19 years with any chronic condition requiring ongoing clinical care, who are leaving or transitioning from…
1 finding from 1 review
Intervention not reported
Healthcare resources use · adolescents between 12 and 19 years with any chronic condition requiring ongoing clinical care, who are leaving or transitioning from…
1 finding from 1 review
Intervention not reported
Patient Activation Measure (PAM) · adolescents between 12 and 19 years with any chronic condition requiring ongoing clinical care, who are leaving or transitioning from…
1 finding from 1 review